Smith M D, Gibson G E, Rowland R
Aust N Z J Med. 1982 Feb;12(1):76-80. doi: 10.1111/j.1445-5994.1982.tb02433.x.
Two cases of hepatotoxicity following sulphasalazine administration are reported. Each patient became ill after her initial exposure to sulphasalazine and after being re-exposed to the drug. In both instances there was an interval of three weeks between receiving the drug for the first time and the onset of the toxic reaction. In the first patient, hepatotoxicity occurred after initial exposure and following the second course of sulphasalazine. Mild neurotoxicity was seen following second exposure to sulphasalazine. In the second patient, hepatotoxicity occurred following the initial exposure to sulphasalazine but after reexposure the only abnormality in liver function tests present was a slight rise in the serum level of gamma glutamyl transpeptidase. In this patient, life-threatening neurotoxicity occurred each time that the patient received sulphasalazine.
报告了两例服用柳氮磺胺吡啶后出现肝毒性的病例。每位患者在首次接触柳氮磺胺吡啶以及再次接触该药物后均发病。在这两例中,首次服用药物至毒性反应发作之间均间隔三周。在首例患者中,初次接触及第二次服用柳氮磺胺吡啶后均发生肝毒性。第二次接触柳氮磺胺吡啶后出现轻度神经毒性。在第二例患者中,初次接触柳氮磺胺吡啶后发生肝毒性,但再次接触后肝功能检查仅出现γ-谷氨酰转肽酶血清水平略有升高。在该患者中,每次服用柳氮磺胺吡啶均发生危及生命的神经毒性。